Medicine recalls, shortages and safety updates in the UK — September 2024

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 14 Oct 2026 08:50.

All Recalls and defects4 Serious shortages (SSP) New approvals3 Drug Safety Update

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

5 Sep 2024Thursday 5 September 2024

open day ◀ ▶ 1 event · 1 important

Drug Safety Update Valproate use in men

A retrospective observational study has indicated a possible association between valproate use by men around the time of conception and an increased risk of neurodevelopmental disorders in their child…

What this means, batches, details

Loading…

details and permanent link Drug Safety Update on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

In total 1 event this month.

Key

class 1 recall (risk to life)

class 2–3 recall, serious shortage, safety update

class 4 defect notification, new approval

A batch recall does not mean the medicine is withdrawn: it remains licensed, only the listed batches are affected.

Sources

MHRA alerts — medicines recalls and defect notifications since January 2024.
Drug Safety Update.
Serious Shortage Protocols (NHSBSA).